Cymbalta Alternatives Compared
Cymbalta | Buprenex | Oxycodone |
|
---|
Cymbalta (duloxetine) | Buprenex (buprenorphine) | Oxycodone |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Cymbalta has antidepressant, anti-anxiety, and pain-relieving properties; however, it has been associated with a discontinuation syndrome on withdrawal even when tapered. Prescribed for Back Pain... View more |
Prescription only
Buprenex is a potent analgesic that should be only used to treat moderate to severe pain under strict conditions when other analgesics have proved inadequate. Sedation is the main side effect and it... View more |
Prescription only
Oxycodone is a potent pain-relieving medicine that should be reserved for mainly cancer-related pain. It carries a high potential for addiction and common side effects include sedation and... View more |
Related suggestions |
|||||||||||||||||||||||
More about Cymbalta (duloxetine) | More about Buprenex (buprenorphine) | More about Oxycodone | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Cymbalta has an average rating of 6.2 out of 10 from a total of 1826 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 30% reported a negative effect. |
Buprenex has an average rating of 8.4 out of 10 from a total of 6 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 20% reported a negative effect. |
Oxycodone has an average rating of 7.0 out of 10 from a total of 1108 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 24% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Common side effects include:
See also: Cymbalta side effects in more detail. |
See also: Buprenex side effects in more detail. |
Commonly reported side effects include:
See also: oxycodone side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Cymbalta prices and generic prices |
View all Buprenex prices and generic prices |
View all oxycodone prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other duloxetine brands include: Drizalma Sprinkle, Irenka | Other buprenorphine brands include: Belbuca, Butrans, Sublocade | Dazidox, Endocodone, ETH-Oxydose, Oxaydo, OxyContin, Oxydose, Oxyfast, Roxicodone, RoxyBond, Xtampza ER View more | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
17 hours |
48 hours |
5.6 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 578 drugs are known to interact with Cymbalta:
|
A total of 662 drugs are known to interact with Buprenex:
|
A total of 561 drugs are known to interact with oxycodone:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
N/A |
October 20, 2010 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.